Horizon Pharma PLC (NASDAQ:HZNP)

13.89
Delayed Data
As of Feb 16
 -0.20 / -1.42%
Today’s Change
9.45
Today|||52-Week Range
17.69
-4.86%
Year-to-Date

Today’s Trading

Previous close14.09
Today’s open14.02
Day’s range13.87 - 14.27
Volume1,166,273
Average volume (3 months)1,968,499
Market cap$2.3B
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-516.00%
Earnings growth (this year)-48.86%
Earnings growth (next 5 years)+10.60%
Revenue growth (last year)+38.18%
P/E ratioNM
Price/Sales2.49
Price/Book1.78

Competitors

 Today’s
change
Today’s
% change
AXONAxovant Sciences Ltd-0.01-0.30%
PRTAProthena Corporation...+1.09+3.39%
SUPNSupernus Pharmaceuti...-0.80-2.04%
FOLDAmicus Therapeutics ...-0.66-4.17%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)$0.22
Annual revenue (last year)$1.0B
Annual profit (last year)-$166.8M
Net profit margin-15.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Timothy P. Walbert
Chief Financial Officer &
Executive Vice President
Paul W. Hoelscher
Corporate headquarters
Dublin, Dublin

Forecasts